208 related articles for article (PubMed ID: 28004468)
21. Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice.
Oishi K; Hofmann S; Diaz GA; Brown T; Manwani D; Ng L; Young R; Vlassara H; Ioannou YA; Forrest D; Gelb BD
Hum Mol Genet; 2002 Nov; 11(23):2951-60. PubMed ID: 12393806
[TBL] [Abstract][Full Text] [Related]
22. Thiamine transporter mutation: an example of monogenic diabetes mellitus.
Alzahrani AS; Baitei E; Zou M; Shi Y
Eur J Endocrinol; 2006 Dec; 155(6):787-92. PubMed ID: 17132746
[TBL] [Abstract][Full Text] [Related]
23. Arrhythmia in thiamine responsive megaloblastic anemia syndrome.
Argun M; Baykan A; Hatipoğlu N; Akın L; Şahin Y; Narin N; Kurtoğlu S
Turk J Pediatr; 2018; 60(3):348-351. PubMed ID: 30511554
[TBL] [Abstract][Full Text] [Related]
24. Thiamine-responsive megaloblastic anemia syndrome with Ebstein anomaly: a case report.
Akbari MT; Zare Karizi S; Mirfakhraie R; Keikhaei B
Eur J Pediatr; 2014 Dec; 173(12):1663-5. PubMed ID: 24357267
[TBL] [Abstract][Full Text] [Related]
25. Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness.
Labay V; Raz T; Baron D; Mandel H; Williams H; Barrett T; Szargel R; McDonald L; Shalata A; Nosaka K; Gregory S; Cohen N
Nat Genet; 1999 Jul; 22(3):300-4. PubMed ID: 10391221
[TBL] [Abstract][Full Text] [Related]
26. Thiamine-responsive megaloblastic anemia syndrome: a novel mutation.
Yilmaz Agladioglu S; Aycan Z; Bas VN; Peltek Kendirci HN; Onder A
Genet Couns; 2012; 23(2):149-56. PubMed ID: 22876572
[TBL] [Abstract][Full Text] [Related]
27. A novel mutation in the SLC19A2 gene in a Turkish female with thiamine-responsive megaloblastic anemia syndrome.
Yeşilkaya E; Bideci A; Temizkan M; Kaya Z; Camurdan O; Koç A; Bozkaya D; Koçak U; Cinaz P
J Trop Pediatr; 2009 Aug; 55(4):265-7. PubMed ID: 18614593
[TBL] [Abstract][Full Text] [Related]
28. [Thiamine-responsive megaloblastic anemia or Rogers syndrome: A literature review].
Lu H; Lu H; Vaucher J; Tran C; Vollenweider P; Castioni J
Rev Med Interne; 2019 Jan; 40(1):20-27. PubMed ID: 30031565
[TBL] [Abstract][Full Text] [Related]
29. The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight families.
Raz T; Labay V; Baron D; Szargel R; Anbinder Y; Barrett T; Rabl W; Viana MB; Mandel H; Baruchel A; Cayuela JM; Cohen N
Hum Mutat; 2000; 16(1):37-42. PubMed ID: 10874303
[TBL] [Abstract][Full Text] [Related]
30. Thiamine responsive megaloblastic anemia with a novel SLC19A2 mutation presenting with myeloid maturational arrest.
Dua V; Yadav SP; Kumar V; Khan AA; Puri R; Verma I; Flanagan SE; Ellard S; Sachdeva A
Pediatr Blood Cancer; 2013 Jul; 60(7):1242-3. PubMed ID: 23512295
[No Abstract] [Full Text] [Related]
31. Diabetic acido-ketosis revealing thiamine-responsive megaloblastic anemia.
Bouyahia O; Ouderni M; Ben Mansour F; Matoussi N; Khaldi F
Ann Endocrinol (Paris); 2009 Dec; 70(6):477-9. PubMed ID: 19922902
[TBL] [Abstract][Full Text] [Related]
32. Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia.
Shaw-Smith C; Flanagan SE; Patch AM; Grulich-Henn J; Habeb AM; Hussain K; Pomahacova R; Matyka K; Abdullah M; Hattersley AT; Ellard S
Pediatr Diabetes; 2012 Jun; 13(4):314-21. PubMed ID: 22369132
[TBL] [Abstract][Full Text] [Related]
33. Thiamine responsive megaloblastic anemia: the puzzling phenotype.
Beshlawi I; Al Zadjali S; Bashir W; Elshinawy M; Alrawas A; Wali Y
Pediatr Blood Cancer; 2014 Mar; 61(3):528-31. PubMed ID: 24249281
[TBL] [Abstract][Full Text] [Related]
34. Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing deafness.
Onal H; Bariş S; Ozdil M; Yeşil G; Altun G; Ozyilmaz I; Aydin A; Celkan T
Turk J Pediatr; 2009; 51(3):301-4. PubMed ID: 19817279
[TBL] [Abstract][Full Text] [Related]
35. Loss-of-Function Mutation in Thiamine Transporter 1 in a Family With Autosomal Dominant Diabetes.
Jungtrakoon P; Shirakawa J; Buranasupkajorn P; Gupta MK; De Jesus DF; Pezzolesi MG; Panya A; Hastings T; Chanprasert C; Mendonca C; Kulkarni RN; Doria A
Diabetes; 2019 May; 68(5):1084-1093. PubMed ID: 30833467
[TBL] [Abstract][Full Text] [Related]
36. Thiamine Responsive Megaloblastic Anaemia, Diabetes Mellitus and Sensorineural Hearing Loss in a Child.
Khurshid A; Fatimah S; Altaf C; Malik HS; Sajjad Z; Khadim MT
J Coll Physicians Surg Pak; 2018 Sep; 28(9):S169-S171. PubMed ID: 30173687
[TBL] [Abstract][Full Text] [Related]
37. Whole-Exome Sequencing Revealed a Pathogenic Nonsense Variant in the SLC19A2 Gene in an Iranian Family with Thiamine-Responsive Megaloblastic Anemia.
Mohsen-Pour N; Naderi N; Ghasemi S; Hesami M; Maleki M; Kalayinia S
Lab Med; 2022 Nov; 53(6):640-650. PubMed ID: 35686496
[TBL] [Abstract][Full Text] [Related]
38. Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome.
Diaz GA; Banikazemi M; Oishi K; Desnick RJ; Gelb BD
Nat Genet; 1999 Jul; 22(3):309-12. PubMed ID: 10391223
[TBL] [Abstract][Full Text] [Related]
39. Identification of four SLC19A2 mutations in four Chinese thiamine responsive megaloblastic anemia patients without diabetes.
Liu G; Yang F; Han B; Liu J; Nie G
Blood Cells Mol Dis; 2014 Apr; 52(4):203-4. PubMed ID: 24355766
[No Abstract] [Full Text] [Related]
40. Pancytopenia in an adult patient with thiamine-responsive megaloblastic anaemia.
Moulin V; Grandoni F; Castioni J; Lu H
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29903777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]